Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of tofacitinib in COVID-19
IRCT20200329046892N2Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tofacitinib in coronavirus disease 2019 (COVID-19), sponsored by Guilan University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200329046892N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200329046892N2.